Drug intelligence / Profile preview

Yiqi Weixue capsules

Development stage: Unknown
Lead developer: Red Coral Pharmaceutical
Administration: Oral

Overview

Yiqi Weixue capsules, marketed under the brand name Yixuebao, is a Traditional Chinese Medicine (TCM) product developed and manufactured by Guangdong Hongshanhu Pharmaceutical (also known as Red Coral Pharmaceutical Group). The formulation is primarily composed of porcine blood cell powder, Astragalus (Huangqi), and Jujube (Dazao). It is indicated for the treatment of anemia, particularly iron-deficiency anemia, and for addressing symptoms of 'Qi and blood deficiency' such as dizziness, fatigue, and palpitations. As a TCM blood tonic, it works by promoting hematopoiesis and improving the body's nutritional status. The product is administered orally in capsule form and is widely available in the Chinese pharmaceutical market.

Brand names: Yixuebao益雪宝
Other names: 益气维血胶囊Yixuebao Yiqi Weixue capsules

Beyond the preview

Go deeper on Yiqi Weixue capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Weixue capsules.

Explore the full profile